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ABSTRACT 
 
 
In the neonate the muscles of the tongue, which are exclusively innervated by the XII 
cranial nerves originating from the brainstem nucleus hypoglossus, must contract 
rhythmically in coincidence with breathing, suckling and swallowing. These motor 
commands are generated by hypoglossal motoneurons excited by glutamatergic inputs. 
Since in forebrain areas the efficiency of glutamatergic transmission is modulated by 
neuronal nicotinic receptors (nAChRs), the role and identity of nAChRs within the 
nucleus hypoglossus of the neonatal rat were explored using an in vitro brainstem slice 
preparation. This area expressed immunoreactivity for α4, α7 and β2 subunits. Whole 
cell patch clamp recording from hypoglossal motoneurons showed lack of spontaneous 
cholinergic events mediated by nAChRs even in the presence of a cholinesterase 
inhibitor. However, pharmacological antagonism of α7 or β2 containing receptors 
depressed glutamatergic currents arising either spontaneously or by electrical 
stimulation of the reticular formation. Hypoglossal motoneurons expressed functional 
nAChRs with characteristics of α4β2 and α7 receptor subunits, and displaying fast 
desensitization (time constant of 200 ms) from which full recovery developed within 
one min. Low (0.5 M) concentration of nicotine first facilitated glutamatergic 
transmission on motoneurons and later depressed it through receptor desensitization. 
When 0.1 M nicotine was used, only depression of synaptic transmission occurred, in 
keeping with the suggestion that nAChRs can be desensitized without prior activation.  
These results highlight the role of tonic nAChR activity in shaping excitatory inputs to 
hypoglossal motoneurons and suggest that their desensitization by ambient nicotine 
could contribute to disorders of tongue muscle movements.
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INTRODUCTION 
 
1.  CENTRAL  CHOLINERGIC  SYSTEM 
 
Acetylcholine (Ach) was first identified as a neurotransmitter with the famous Otto 
Loewi experiments on heart muscle cells (1921) that advanced the chemical 
transmission hypothesis. Ach is synthesized by Choline-Acetyl-Tranferase (ChAT) in 
cholinergic terminals from choline and acetyl-coenzymeA (Ac-SCoA) (Fig. 1). Ac-SCoA 
is produced inside mytochondria; choline is supplied by an active transport system 
from  extracellular  fluid.  After synthesis, Ach is packaged into releasing  vescicles.  The  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Schematic representation of a cholinergic synapse. 
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action of Ach in the synaptic cleft is terminated by ACh-Esterase (AchE), which 
hydrolyzes ACh into choline and acetate. Choline is then taken up into cholinergic axon 
terminals becoming available as substrate for new ACh syntesis. 
 
Besides the neuromuscular junction, Ach acts as a neurotransmitter at autonomic 
ganglia and at some central synapses. The central cholinergic system has not yet been 
completely described, but the available information suggests that it is made up of a 
series of closely connected subsystems (Fig. 2). The major cholinergic subsystems 
originate from groups of neurons located in the basal forebrain and the pons-
mesencephalon.  The basal forebrain  contains two  groups of cholinergic neurons: 
 
   
 
 
Fig. 2. Central cholinergic pathways. Cholinergic neurons in the basal forebrain and pons-
mesencephalon display widespread projections (see text). (scheme adapted from Woolf, 1991). 
 
(1) the medial septal group (medial septal nucleus and vertical diagonal band: ms and 
vdb) that project axons to the hippocampus and para-hippocampal gyrus and (2) the 
nucleus basalis group (nucleus basalis, substantia innominata and horizontal diagonal 
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band: bas, si, hdb) projecting to all parts of the neocortex, parts of limbic cortex and to 
the amygdala. The pontomesencephalon cholinergic neurons (laterodorsal tegmental 
and pedunculopontine tegmental nuclei: ldt and ppt) project onto hindbrain (including 
brainstem), thalamus, hypothalamus and basal forebrain. The striatum contains an 
intrinsic local circuit of cholinergic neurons (reviewed in Woolf, 1991).  Each cholinergic 
neuron innervates a discrete area making contacts with the dendrites of many other 
neurons. This extensive interconnection may lead to coordinate firing of closely spaced 
neurons. 
 
Cholinergic signal is transduced by two different classes of receptors, classified 
according to their pharmacological sensitivity to the exogenous ligands, muscarine and 
nicotine. It is now common knowledge that these two classes of cholinergic receptors 
are members of two receptor super-families structurally and functionally unrelated: 
nicotinic Ach receptors (nAChRs) are ligand gated ion channels, while muscarinic ACh 
receptors (mAChRs) produce their effect through interaction with GTP-binding 
proteins, and are therefore referred to as metabotropic receptors. For a long time it was 
thought that central cholinergic pathways worked mainly through muscarinic synapses. 
The importance of central nAChRs was disclosed by the effect of tobacco smoking on 
behavioral and cognitive functions. Nicotine enhances attention and arousal, diminishes 
anxiety, produces mild analgesia, and can even improve acquisition and retention of 
short-term memories. Furthermore, studies on patients with cognitive or behavioral 
disorders such as Alzheimer’s disease, Tourette syndrome, Parkinson’s disease and 
schizophrenia demonstrate significant alterations in the expression of CNS nAChRs and 
in some case have shown therapeutic effects of nicotine administration (Role and Berg, 
1996; Paterson and Nordberg, 2000). 
 
 
 
 4 
2.  NICOTINIC  ACETYLCHOLINE  RECEPTORS 
 
2.1. MOLECULAR  STRUCTURE 
Best studied at the vertebrate neuromuscular end plate and in the Torpedo electric organ, 
nicotinic acetylcholine receptors (nAChRs) have been, for a long time, a model of 
ligand-gated ion channels (Fig. 3). This class of receptors includes gamma aminobutyric 
acid (GABAA and GABAC), glycine and 5-hydroxytryptamine (5-HT3) receptors. All 
these proteins are assembled in a pentameric structure across the plasma membrane, 
where they act both as “receptor” and as “effector”: after binding of agonist to the 
ligand-binding sites, the inner pore is opened via a conformational change, permitting 
ions to flow through. 
 
 
 
 
 
 
 
 
 
Fig. 3. The nicotinic acetylcholine receptor works as an ionic channel. 
 
During 1970s the nAChR was purified from muscular tissue and identified as a 290kDa 
glyco-protein. Thereafter, it was identified as made up by five monomers of four 
different types named α, β, γ and δ according to their increasing molecular weight 
(Changeux, 1990). 
Each subunit is a protein with four putative trans-membrane domains (M1, M2, M3, 
M4) (Fig. 4). Other features are: a long N-terminal extra-cellular part presenting 
glycosilation sites; a large intracellular loop comprised between the M3 and M4 
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segments, containing putative phosphorylation sites; a short C-terminal extracellular 
domain. Affinity labeling experiments have shown that: (1) the aminoacids involved in 
the binding of Ach are situated in the long extra-cellular N-terminal domain of two 
adjacent subunits; (2) the ion channel is lined with the second trans-membrane domain 
(M2) of all five subunits, which are crucial for the ion selectivity (Cordero-Erausquin, 
2000; Corringer et al., 2000).   
 
 
 
 Fig. 4. Schematic model of nAChRs structure. Top, this receptor is a membranal       
heteropentameric glyco-protein. Bottom, left and right, the topology of the subunits: M1, M2, M3 
and M4 represent four hydrophobic membrane spanning domains. 
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2.2. NEURONAL  RECEPTOR  SUB-TYPES  
Following the identification of the genes encoding the neuromuscular receptor 
subunits, molecular cloning revealed the existence of homologous sequences in other 
tissues. So far, in vertebrate, twelve more genes that encode for nAChR subunits have 
been identified: 9 α-type (α2-α10) and 3 β-type (β2-β4) (Sargent, 1993; McGehee and 
Role, 1995; Itier and Bertrand, 2001). The subunits are called α or β according to their 
homology to the muscle α1 subunit: assignment to the α subtype group requires the 
presence of two adjacent cysteines, which are though to participate to the Ach binding 
site. The existence of such a large number of subunits available for channel formation 
suggests that they may combine in several ways, creating different channel subtypes 
with distinct biophysical and pharmacological properties. Since individual gene 
products can assemble with different partners depending on the available 
combinations, it is not possible to predict receptor composition simply on the basis of 
the set of genes expressed by the neuron.  
The best characterized receptor subtype is the one found at the skeletal muscle and 
electric organ. On the other hand, on neurons two major classes of nAChRs can be 
described (Fig. 5). Expression of α7, α8 and α9 alone is sufficient for the formation of so 
called “homomeric” channels (although α8 subunit has been found only in avians, not 
in mammals, and the α9 subunit is only expressed by certain endocrine cells and 
sensory-end organs, namely cochlear hair cells). They are thought to contain five ligand 
binding sites, one at each interface between one α and the adjacent subunit (Elgoyhen et 
al., 1994; Broide and Leslie, 1999; Millar, 2003). Whereas channels formed by co-
expression of α and β subunits are said to be “heteromeric”, α2, α3 and α4 subunits can 
form functional AChRs when expressed in combination with β2 or β4 subunits. The 
predominant brain subtypes preserve the stoichiometry of muscle receptors, with two α 
and three non-α subunits, and consequently two agonist binding sites. The prevalent 
brain subtype has been shown to possess the stoichiometry (α4)2 (β2)3. It has also been 
reported that a co-assembly of the α7 and β2 subunits might occur, when these subunits 
 7 
are co-expressed in Xenopus oocytes; perhaps this co-assembly may help to explain 
some nAChR channel diversity in the nervous system (Khiroug et al., 2002). 
An even more complex subgroup of heteromeric subtypes has been described: “triplex” 
receptors containing more than one type of α or β subunit, including the α5, α6 and β3 
subunits; these subunits are unable to form channels when expressed alone or as a pair 
with any other single α or β subunit (Conroy and Berg, 1995; Le Novere et al., 1996; 
Wang et al., 1996; Colquhoun and Patrick, 1997; Groot-Kormenlink et al., 1998; Yu and 
Role, 1998; Lindstrom, 2000). These subunits are also known as auxiliary subunits 
because they do not directly participate in the formation of the ligand binding site; they 
probably occupy the same relative position as β1 subunit in muscle nAChRs, and may 
have a role in controlling either ion permeability, desensitization or receptor location. 
 
                                                          
                                       muscle nAChR                                          neuronal  
                                                                                                     heteromeric nAChR 
 
 
                                                          
                                       neuronal                                                   neuronal  
                                    homomeric nAChR                    “triplex” heteromeric nAChR 
 
 
Fig. 5. Different classes of nAChR subtypes: subunit stoichiometry and arrangement (modified 
from Wang et al., 1996). 
 
 8 
2.3. FUNCTIONAL  PROPERTIES 
After agonist binding, the ion channel is stabilized in the open conformation for several 
milliseconds. Through the opened pore cations can freely flow, causing a local 
depolarization of the cell membrane and eventually an intracellular signal. Beside 
sodium and potassium, also calcium takes part in this ionic current (Vernino et al., 1992; 
Seguela et al., 1993; Fucile, 2004; Oikawa et al., 2005). Calcium entry mediated by 
nAChRs is different from its flow through voltage-gated channels or the N-methyl-D-
aspartate (NMDA) glutamatergic receptor subtype.  Nicotinic receptors can mediate 
calcium entry at resting or hyperpolarized membrane potential, while voltage-gated 
calcium channels and NMDA receptors require membrane depolarization to activate. 
Moreover, calcium entry may have different biological relevance depending on the 
spatial distribution of nAChRs on the cell surface. 
 
Beside their closed resting and the open conducting states, nicotinic receptors show 
another basic conformational state, namely the desensitized one. As a consequence of 
prolonged exposure to the agonist, the channel closes to a reversible, non-conducting 
state that remains unresponsive until agonist comes off the binding sites. Katz and 
Thesleff (1957) first described in detail desensitization of muscle nAChRs. In their 
report they proposed a cyclical scheme in which nAChRs may exist in two functional 
states: the resting or activable (R) and the desensitized (D) (Fig. 6). The R conformation 
has a relatively low affinity and requires high concentrations of agonist to couple 
binding to channel opening. In contrast, the D state has a higher affinity for agonist; 
therefore at low concentrations, ligand binds to pre-existing D receptors, stabilizing the 
desensitized conformation. The disrupted equilibrium between R and D states is 
restored by transition of receptor molecules from R to D, and, after sufficiently long 
time, all receptors will end up desensitized. Hence desensitization can occur even at 
quite low concentration of agonist (Katz and Thesleff, 1957; Quick and Lester, 2002).  
During the past decades the idealized model for nAChRs has changed from a simple 
on-off cationic conductance to a sophisticated allosteric molecule (Changeux et al., 
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1984). Changeux and co-workers suggested that desensitization represents a classical 
form of allosteric protein behavior, which the receptor acquires in the absence of the 
agonist. Moreover, they introduced an intermediate desensitized state (I), in order to 
reflect the non-exponential time course of desensitization onset and recovery (Feltz and 
Trautmann, 1982; Boyd, 1987; Edelstein and Changeux, 1998). In this picture nicotinic 
receptors can exist in at least four interconvertible and functionally distinct 
conformational states (Fig. 6). In the absence of the ligand, the receptor spontaneously 
changes state, but even if a transition is possible, the probability of channel opening is 
extremely low. The four described allosteric states are named R, A, I and D. At resting 
conditions, the closed (R) state is the main one, however, some molecules are always in 
the desensitized (D) state. Exposure to the agonist preferentially stabilizes the active (A) 
open state and then subsequently the intermediate (I) closed state and finally, with a 
slower time constant, the desensitized (D) closed state. 
 
                                        
                (Katz and Thesleff, 1957)                                         (Changeux et al., 1984) 
 
Fig. 6. Kinetic models for nAChR desensitization. Left: cyclical scheme for desensitization of 
nAChRs, where L is the allosteric constant reflecting the distribution of receptors in the R/D 
state, and K0 and K1 are the ligand constant affinities relative to the R and D state, respectively. 
Right: cyclical model that includes two desensitized states, of intermediate (I) or high (D) 
affinity. (modified from Quick and Lester, 2002).  
 
 
 Both nicotine and ACh can produce desensitization at concentrations that do not 
activate a significant fraction of their receptor population necessary to elicit a 
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macroscopic response (Paradiso and Steinbach, 2003). The physical nature of the 
multiple desensitized states is not known, but it has been proposed that one (or more) 
of the slowly recovering processes may reflect phosphorylation changes. 
Phosphorylation may also regulate movements between functional and inactive pools 
of receptors (Huganir et al., 1986; Boyd, 1987; Fenster et al., 1999).  
 
The kinetic constants governing the rate of conformational changes, as well as the ion 
permeability in the open state, depend on many factors including the subunit 
composition. The relations between channel structure and its function can be mainly 
established thanks to heterologous expression studies in which host cells, usually 
Xenopus oocytes, are injected with the appropriate mRNA or cDNA. Oocytes do not 
normally express native nicotinic receptors, yet after appropriate injections, functionally 
active channels are generated, and their currents are studied by means of 
electrophysiological techniques. 
Both α and β subunits contribute to the pharmacological and functional profiles. In 
particular, there are clear distinctions among the neuronal nAChR complexes, whether 
generated by the expression of a single α-type subunit (homomeric) or by co-expression 
of α and β subunits (heteromeric) (McGehee and Role, 1995; Role and Berg, 1996). α7-
homomeric receptors display greater calcium permeability and can be gated either by 
ACh or by choline; this receptor subtype often shows fast onset of desensitization. 
While the exact number of receptors that falls into the heteromeric class remains to be 
elucidated, it is thought that receptors containing β2 subunits desensitize faster than 
those containing β4 subunits, independently of the α subunit expressed. Conversely, 
receptors containing α3 subunits desensitize faster than those containing α4 (Fenster et 
al., 1997; Quick and Lester, 2002; Wang and Sun, 2005). All these classes of receptors 
may be involved in different aspects of ACh function in the CNS. For instance, acting 
via homomeric receptors, ACh can induce short-lived or phasic membrane 
depolarizations, while acting via heteromeric receptors, ACh can generate sustained or 
tonic depolarization (Tribollet et al., 2004).  
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At a cholinergic synapse, approximately 1-3 mM ACh is rapidly released into the cleft, 
immediately activating nicotinic receptors. In few milliseconds ACh is hydrolyzed by 
the esterase and/or diffuses away. The half-time of ACh is very short and therefore 
desensitization is usually not thought to be important in physiological conditions. But 
at very active synapses when repeated pre-synaptic inputs occur, nAChRs are more 
susceptible to desensitization. In these conditions the onset of desensitization may 
prevent excessive stimulation because all nAChRs are Ca++ permeable (McGehee and 
Role, 1995), and therefore potentially excitotoxic to neurons. Moreover, several workers 
have suggested that the selective desensitization of one receptor subtype, while other 
subtypes remain active, may play a significant role in changing the plasticity of 
particular brain networks. The physiological role of desensitization may become 
especially important when considering nicotine plasma levels in smokers (Ochoa et al., 
1990; Dani and Heinemann, 1996), or the effect of drugs that inhibit ACh-Esterase (used, 
for instance, to treat Alzheimer’s disease). 
 
In addition, a variety of pharmacological agents regulating the functional states of 
nAChRs has been described (Lena and Changeux, 1993), like extracellular calcium 
which increases the ACh evoked current at α7 homomeric receptors, and a  calcium 
recognition site was identified near the ACh binding site. Similarly, heteromeric 
receptors show sensitivity to zinc: in particular β4-containing receptors are potentiated 
by low concentrations of zinc, while β2 receptors are inhibited (Vernino et al., 1992; 
Hsiao et al., 2001). 
 
The wide diversity of nAChR subtypes, although problematic for investigators, allows 
sensitive tuning of the cholinergic transmission.  
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 2.4. PHARMACOLOGY  
Different subunit combinations determine topographical variations at the ligand 
binding site, which in turn accounts for the pharmacological differences among 
nicotinic receptor populations. Ach is the major endogenous ligand for all nicotinic 
receptors subtypes, while its metabolite choline selectively gates the α7 subtype 
(Alkondon et al., 1997). The exogenous alkaloid nicotine, present in Nicotiana tabacum, 
mimics the effect of ACh activating all nAChR subtypes, and even epibatidine, the most 
potent natural agonist at nAChRs, obtained from skin extracts of an Amazonian frog, is 
not subtype specific (Badio and Daly, 1994).  
Pharmacological criteria have been used to classify nAChR subtypes, first of all the 
different sensitivity of nAChRs to the snake toxin α-bungarotoxin (α-BTX) (Clarke et al., 
1985). It was shown that homomeric receptors α7, α8 and α9 are blocked by α-BTX, 
whereas heteromeric receptors are insensitive to this toxin (McGehee and Role, 1995). 
Another natural compound acting on homomeric nAChR subtype is the alkaloid 
methyllycaconitine (MLA). The great advantage of using MLA is that its effect is 
completely reversible. By the way, its action is selective, rather than specific because 
MLA binds to α7 receptors with a Ki near to 1 nanomolar, while muscle and α4β2 
nAChRs require much higher concentrations for inhibition (Alkondon et al., 1992; Palma 
et al., 1996). On the other hand, the alkaloid di-hydro-β-erythroidine (DHβE), isolated 
from Erythrina seeds, displays heteromeric subtype specific antagonism at sub-
micromolar concentrations (Harvey et al., 1996; Chavez-Noriega et al., 1997). Also the 
venoms extracted from Conus snails are an interesting source for pharmacologically 
active drugs, among which the α-conotoxin MII, at nanomolar concentrations, showed a 
potent and selective antagonism for the α3β2 nAChR subtype (Cartier et al., 1996; 
Harvey et al., 1997; Kaiser et al., 1998). Competitive antagonists displace the agonist 
from its binding sites, whereas open channel blockers, such as mecamylamine, bind 
within the pore, and there are multiple sites for other non-competitive inhibitors and 
modulators such as physyostigmine and galanthamine (Pereira et al., 1994; 
Schrattenholz et al., 1996). In addition, nAChRs activity is subjected to regulation by 
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several other factors, including peptide transmitters, various protein kinases, and Ca++ 
(Hopfield et al., 1988; Mulle et al., 1992; Davis et al., 2001).  
A general problem in addressing nAChR function in the brain remains the lack of 
specific agonists and antagonists for each of the receptor subtypes.  
  
2.5. RECEPTORS  DISTRIBUTION  AND  LOCATION  
Much of the current knowledge regarding neuronal nAChRs has been obtained from in 
vitro binding studies (Marks et al., 1986). In situ hybridization and 
immunohistochemical experiments have furthered our understanding of native 
nAChRs composition (Wada et al., 1989). These studies indicate a wide and non-uniform 
distribution of various nAChR subunits. Although one class of nicotinic receptor often 
predominates within a region, usually more than one subtype is detectable.  
Nevertheless, the most diffuse receptor subtype in vertebrate nervous system seems to 
be the α4β2 subtype, which can also contain α5 subunit, and the α3β4 subtype, with or 
without α5. These receptors, corresponding to high-affinity binding sites for nicotine, 
have been detected in the thalamus, hippocampus, substantia nigra, striatum, cerebral 
cortex and cerebellum. The α6
 
containig receptors, very often in conjunction with the β3 
subunit, are present in the optic pathway, the locus coeruleus and dopaminergic neurons 
of the mesostriatal pathways where they control dopamine release (Picciotto et al., 1998; 
Perry et al., 2002). The α7
 
containig receptors, which account for α-BgTX binding (Orr-
Urtreger et al., 1997), are also rather diffuse, particularly in the hippocampus, 
hypothalamus, cortex and brainstem, whereas α9/α10
 
containing receptors are present 
extra-neuronally in limited area such as the olfactory epithelium and the cochlea (Gotti 
et al., 1997).  
 
nAChRs are strongly expressed early in embryonic life, suggesting their role during 
development (Zoli et al., 1995; Agulhon et al., 1999a; 1999b). Varying the level of 
intracellular Ca++ can have strong consequences on cell metabolism, from altering gene 
expression to triggering apoptotic cell death (Ghosh et al., 1995; Broide et al., 1999).  
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In the periphery, neuronal nAChRs have been detected not only in ganglionic tissue, 
but also in developing and denervated muscle, on keratinocytes and on peripheral 
blood cells, notably polymorphonuclear cells and lymphocytes (Gotti and Clementi, 
2004).  
 
Anatomical and functional evidence suggests that neuronal nAChRs are preferentially 
located on pre-synaptic boutons where they contribute to the regulation of secretion of 
other neurotransmitters via sustained Ca++ influx (Wonnacott, 1997). In many cases the 
α7 subtype, which is the most permeable to calcium among the nAChRs class, mediates 
increased synaptic release, but in some cases other subtypes are involved. Indeed, the 
magnitude and time course of pre-synaptic facilitation elicited by nAChR activity 
differs from synapse to synapse, and these differences may be the result of receptor 
composition (Grady et al., 1992; Guo et al., 1998; Alkondon et al., 1999). Activation of 
pre-synaptic nAChRs enhances the release of many neurotransmitters in diverse 
regions of the brain. In particular, pre-synaptic nAChRs have been implicated in the 
release of ACh, norepinephrine, dopamine, glutamate and GABA (McGehee et al., 1995; 
Maggi et al., 2001). It is common knowledge that nicotine addiction is mediated by the 
influence of nAChRs on dopamine release in the mesolymbic pathway (Wonnacott, 
1997; Fisher et al., 1998; Li et al., 1998; Radcliffe et al., 1999). Certainly, the presence of 
cholinergic projections within terminal fields displaying nAChRs is suggestive of 
endogenous cholinergic activation via pre-synaptic nAChRs. 
In addition to controlling and modulating the release of various neurotransmitters, pre-
synaptic nAChRs may play an important role in regulating neuronal growth, path-
finding and differentiation.  
Nicotinic receptors can modulate neurotransmitter release also at peri-terminal 
locations. Due to the high impedance of pre-terminal fibers, the gating of relatively few 
axonal nAChRs may elicit significant changes in synaptic excitability. nAChRs 
activation may initiate Na+-mediated axonal membrane depolarization, which in turn 
activates Ca++ entry through voltage gated channels. This action is blocked by 
 15 
tetrodotoxin which prevents voltage-gated sodium channel opening and therefore stops 
depolarization advancing (Lena et al., 1993). Moreover, strategically located nAChRs 
might enable activation of only selective portions of the axonal arborization. 
There is also evidence that high-affinity, nicotine binding nAChRs are located on 
postsynaptic membranes (Clarke, 1993). Many neurons can generate fast inward 
currents in response to exogenously applied Ach, but relatively few direct nicotinic 
synapses have been documented in the mammalian brain. These receptors are regarded 
to mediate fast excitatory synaptic transmission on GABAergic interneurons in the 
hippocampus, and on both glutamatergic pyramidal cells and GABAegic interneurons 
in the developing visual cortex (Roerig et al., 1997; Alkondon et al., 1998). In many cases 
nicotinic transmission is a minor component of the excitatory input, which is 
overwhelmingly glutamatergic (Collingridge and Lester, 1989). 
 
 
 
Fig. 7. Schematic representation of nAChR locations: (left) pre-synaptic, (center) peri-synaptic, 
(right) post-synaptic. 
 
 
The intrinsic difficulty in studying central cholinergic synapses arises from anatomical 
considerations (Wolf, 1991): cholinergic projections are diffuse and nAChR containing 
targets are scattered throughout the brain. The density of synapses is rather low and 
therefore they are difficult to detect in a brain slice preparation, which is a commonly 
used experimental model. 
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It is thought that the physiological role of cholinergic systems may be regulating the 
gain and fidelity of synaptic processes by increasing the signal-to-noise ratio. Properly 
timed nAChR activity could facilitate transmitter release and boost the efficiency of 
synaptic transmission, ensuring that important events emerge out via enhanced 
synaptic probability of transmitter release (Maggi et al., 2003; 2004). It is this fidelity that 
might be lost by the impairment in nicotinic function in the hippocampus during 
Alzheimer’s disease. 
In addition to controlling pre or post-synaptic element activation, nAChRs may regulate 
several cell functions, activating various downstream events simply increasing 
intracellular Ca++ levels. Receptor location itself, together with the cellular machinery 
accessible from that site, is highly determinant for calcium-dependent processes (Berg 
and Conroy, 2002). 
 
 
 
3. A MODEL SYSTEM FOR STUDYING NICOTINIC RECEPTOR  
FUNCTION: THE  HYPOGLOSSAL  MOTONEURONS 
 
3.1. MOTOR NEURONS 
For a long time after the studies by Sherrington and Eccles, motoneurons have been 
considered to be paradigmatic to understand how neurons work. Many of the basic 
properties of neurons, and even the fundamental statement that chemical 
neurotransmission is the principal form of neuronal communication, were first 
identified in motoneurons. A huge amount of information relative to neuronal 
properties has been collected, but one difficulty in properly understanding all this is 
due to the absence of data concerning how neurons process incoming synaptic signal 
into actual function. In this regard motoneurons display special advantage, since their 
information coding is translated into action potential discharges, which, in turn, 
produce contraction of skeletal muscular fibers.  
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Although excitatory synaptic transmission to motoneurons is mainly glutamatergic, 
other neurotransmitters may contribute to excitatory input, among which ACh 
(Connaughton  et al.,1986). In mammals, nAChRs not only play a crucial role in muscle 
contraction, but also modulate motoneurons excitability via Renshaw cells activation 
(Eccles et al., 1954; Dourado and Sargent, 2002). Both spinal and cranial motoneurons 
are contacted by choline acetyltransferase (ChAT) containing axon terminals. Moreover, 
it has been shown that either class of motoneurons expresses functional nAChRs 
(Zaninetti el al., 1999; Ferreira el al., 2001; Ogier el al., 2004). In-situ hybridization 
experiments performed by Wada and colleagues (1989) have revealed the presence of 
mRNA strands relative to many nAChR subunits in several brainstem nuclei including 
trigeminal (V), facial (VII), vagal (X) and hypoglossal (XII) nuclei.  
 
 
                  
 
Fig. 8. Brainstem, ventral view. 
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3.2. NUCLEUS  HYPOGLOSSUS 
A suitable model for studying nAChR function in the CNS is the hypoglossal nucleus. It 
is a dense motor-nucleus, easily identifiable within the brainstem. It is located 
bilaterally to the medullary midline just beneath the floor of the forth ventricle; its 
rostro-caudal extent roughly covers the same length as the olive.                                                                                                                                     
At least 90% of neurons within the hypoglossal nucleus are motoneurons (Viana et al., 
1990) although there is anatomical evidence for a small population of interneurons 
(Boone and Aldes, 1984; Takasu and Hashimoto, 1988). However, interneurons are 
smaller (10-20 µm) than hypoglossal motoneurons (HMs) themselves (20-40 µm). 
Moreover, interneurons show few dendritic processes and are confined to the 
ventrolateral or dorsolateral borders of the nucleus. On the other hand, HMs are large 
multipolar neurons spreading dendrites extensively within the hypoglossal nucleus and 
also into the neighboring reticular formation. Axons from HMs travel ventrally through 
the medulla and then emerge to form the hypoglossal nerve (XII cranial nerve, c.n.), 
which innervates the tongue (Lowe, 1980).   
Lingual musculature comprises intrinsic and extrinsic muscles. The former have no 
bone anchoring and are located within the body of the tongue. They include vertical, 
transversal, superior, and inferior longitudinal muscles: their activity shapes the tongue. 
The extrinsic muscles have clear bony attachment, and include the genioglossus, 
geniohyoid, styloglossus, hyoglossus and palatoglossus, whose activity is fundamental 
in tongue protrusion, retraction, depression and elevation. The hypoglossal motor 
nucleus is myotopically organized. In the rat, HMs innervating tongue protruder 
muscles are located in the ventrolateral part of the XII nucleus, whereas HMs sending 
axons to retractor muscles are located more dorsally (Lewis et al., 1971; Krammer et al., 
1979; Dobbins and Feldman, 1995).  
Various peripheral sites (trigeminal, vagal and hypoglossal nerves), brain stem centers, 
and higher centers have been shown to exert an influence on XII motoneuron activity 
(Borke et  al.,  1983;  Takada  et  al.,  1984;  Li  et  al.,  1993;  Dobbins  and  Feldman,  1995; 
Ugolini,  1995;  Sahara   et  al.,  1996;   Hostelge  et  al.,  1997;   Jean,   2001;   Zhang  et  al.,  
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Fig. 9. Sagittal section of the head showing tongue’s musculature and its relative innervation. 
(freely adapted from Frank H.Netter’s Anatomical atlas). 
 
2001); anyway, no   direct  cortical connections to orofacial motor nuclei, including the 
XII, have been demonstrated in rats, confirming that voluntary motor commands to 
motoneurons pass through various relay stations (Travers and Norgren, 1983).  
It is the lateral reticular formation (LRF) that provides the primary source of inputs to 
the XII nucleus. In particular, hypoglossal premotor neurons are ventrolateral and 
dorsolateral in the medullary reticular formation (Borke et al., 1983; Travers and 
Norgren, 1983). The origin of LRF projections was localized to the nucleus reticularis 
parvocellularis (RPc) (Zhang and Luo, 2003). And in turn, RPc receives afferents from 
the trigeminal (V) and solitary nuclei (Lowe, 1980; Borke et al., 1983; Dobbins and 
Feldman, 1995; Luo et al., 2001). RPc is regarded as the brainstem center that coordinates 
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motor sequences of mastication, swallowing, respiration and vocalization. Some of 
hypoglossal premotor neurons are GABAergic, glycinergic, or glutamatergic 
(Collingridge and Lester, 1989; Singer et al., 1996; Li et al., 1997; O'Brien et al., 1997; 
O'Brien and Berger, 1999). The integration of all these synaptic inputs, in concert with 
the intrinsic membrane properties of motoneurons themselves, determines the output 
signals (Berger, 2000). 
 
The cholinergic neurons in the laterodorsal tegmental and pedunculopontine tegmental 
nuclei (LTD/PPT) are thought to provide the primary source of cholinergic projections 
to the hypoglossal nuclei (Connaughton et al., 1986). Immuno-cytochemical experiments 
performed using Ab against choline acetyl-transferase (ChAT) and the vescicular ACh 
trasporter (VAChT) has revealed the presence of staining fibers forming large 
puncta/spots around motoneuron cell bodies and dendrites in the hypoglossal nucleus, 
suggesting that this nucleus is the target of cholinergic innervation (Gilmor et al., 1996; 
Arvidsson et al., 1997; Schäfer et al., 1998; Ferreira et al., 2001). An intriguing possibility 
is that these motoneurons, by virtue of recurrent axon collaterals, could influence the 
activity of neighbouring cells via post-synaptic nAChRs. Such a direct synaptic 
coupling between motoneurons, already established in some motor systems, could 
facilitate motor unit recruitment, and enhance the synchrony of synergistic motoneuron 
firing (Perrins and Roberts, 1995). 
Electrophysiological studies reported that all HMs, regardless of their location, respond 
to stimulation by nicotinic agonists (Zaninetti et al., 1999; Chamberlin et al., 2002; Shao 
and Feldman, 2005). Very recent studies demonstrate positive immunoreaction in HMs 
for various nAChR subunits, suggesting a role for nicotinic receptors in the regulation 
of hypoglossal nucleus activity (Ferreira et al., 2001; Dehkordi et al., 2005). The density 
and distribution of nAChRs, assessed through binding experiments, is higher in the 
whole brainstem during embryonic and postnatal development in comparison with 
adult animals. Similar data are found in cortical and hippocampal tissue as well, 
suggesting a role for nAChRs in the maturation of all these brain structures (Tribollet et 
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al., 2004). It is feasible that increased nAChR expression may be related, and possibly 
contribute, to the establishment of functional neuronal connectivity. 
  
As the XII nerve innervates the tongue, HMs are engaged in several motor functions, 
including suckling, swallowing, and mastication (Jean, 2001). Moreover, because of 
tongue’s critical position in the upper airways, the hypoglossal nucleus is also active 
during respiration (Strohl et al., 1980). Rhythmic HMs activity, strictly correlated with 
the inspiratory burst generated in the pre-Bötzinger complex of the lower brain stem, 
has been monitored in different experimental systems, both in “in vivo” (Richmonds 
and Hudgel, 1996; Pierrefiche et al., 1997) and “in vitro” conditions (Suzue, 1984; 
Murakoshi et al., 1985; Smith et al., 1991; Funk et al., 1993; Ballanyi et al., 1999). It is 
noteworthy that nicotine not only increases respiratory rhythm, but also the activity of 
HMs, in particular of those projecting to the genioglossus muscle (the major extrinsic 
tongue protruder muscle), whose function is fundamental for the maintenance of upper 
airway patency (Remmers et al., 1978; Shao and Feldman, 2001; Robinson et al., 2002; 
Shao and Feldman, 2002).  Indeed, many investigators suggest a clinical use of nicotinic 
agonists in the treatment of obstructive-sleep-apnea, a disease that involves sleep 
related loss of genioglossus muscle tone (Strohl et al., 1980; Gothe et al., 1985; 
Bellingham and Funk, 2000). 
 
 
 
4. AIMS OF THE PRESENT STUDY 
 
The purpose of this study was to investigate whether nAChRs expressed in the nucleus 
hypoglossus are functional, to explore their pharmacological characteristics and their 
role in modulating glutamatergic transmission at early postnatal age. Furthermore, we 
investigated how nicotine can desensitize nAChRs and consequently affect 
glutamatergic transmission on HMs. Although nAChRs can control the activity of 
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inhibitory neurons, a large number of studies have indicated that the main action of 
nAChRs is to modulate glutamate mediated transmission. Hence, in the present report, 
we deliberately restricted the experimental variables of our in vitro model by 
systematically blocking GABA and glycine mediated inhibition. This enabled us to 
study glutamatergic events in isolation and to ascertain their efficiency in the presence 
of nicotinic agonists or antagonists in concert with changes in postsynaptic nACh 
activity.               
In view of the adverse effect of prenatal nicotine exposure on nervous system 
development (Nordberg et al., 1991; DiFranza and Lew, 1995; Slotkin et al., 1999; 
Robinson et al., 2002), it is still an open question the mechanism by which maternal 
smoking affects the neonate’s ability to generate motor commands to the tongue 
muscles responsible for breathing and milk suckling. The basic mechanisms that might 
underlie this important issue were investigated by testing the effect of small 
concentrations of nicotine, similar to those found in the plasma of smokers, on 
glutamatergic transmission in neonatal rat HMs. 
 
 
 
 
 
 
 
 
 
 23 
METHODS 
 
1.  TISSUE  PREPARATION  
Experiments were carried out on brainstem acute slices obtained from neonatal Wistar 
rats (from 0 to 5 days old; P0-5) according to the method previously described by Viana 
et al., (1994). Animals were decapitated after being anaesthetized with intraperitoneal 
injection of urethane (2 g/kg body wt). This procedure is in accordance with the 
regulations of the Italian Animal Welfare Act following the European Community 
directives and approved by the local authority veterinary service.  
Thereafter, the brainstem was quickly removed and submerged in ice-cold saline (for 
composition see below). Cooling of the preparation was particularly important, because 
it minimized damage from anoxia and improved the texture of the tissue for slicing. A 
vibrating tissue slicer (Vibracut, FTB, Weinheim, Germany) was used to cut 200 µm 
thick slices. Mechanical stability of the tissue during slicing was essential. For this 
purpose a tissue block containing the lower medulla was fixed (using insect pins) onto 
an agar block (4 % in 0.9 % NaCl) shaped to contain the tissue in the correct orientation 
(caudal-end up). The block was then glued to the stage of the vibro-slicer and immersed 
in ice-cold physiological saline, saturated with 95% O2 -5% CO2. 
Slices were first transferred to an incubation chamber containing gassed Krebs solution, 
kept there for 1 hour at 32°C and then allowed to slowly reach room temperature. After 
this recovering period, single brainstem slices, were placed in a small recording 
chamber, held in place by a fine nylon net glued to a horse-shaped platinum wire and 
continuously perfused (2-3 ml/min) with the recording Krebs solution (see below). 
Hypoglossal motoneurons (HMs) were identified within the nXII (Fig. 10) with a Zeiss 
Axioscope microscope connected to an infrared video camera (Fig. 11). Under x40 
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magnification single HMs were clearly visible and showed a large soma (20-40 µm 
diameter).    
 
          
B
A
 
XII
 
 
Fig. 10. Neonatal rat brain-stem transverse slice; immunostaining of the hypoglossal nucleus  
(XII) with anti-ChAT (choline acetyl-transferase) antibodies. (scale bar: 200 µm, courtesy of E. 
Fabbretti) 
 
 
                                              
 
Fig. 11. Hypoglossal motoneurons from P2 rat brain stem slice (scale bar: 50 µm, courtesy of S.E. 
Pagnotta) 
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2.  SOLUTIONS  AND  DRUGS 
 
2.1. SLICE PREPARATION AND MAINTENANCE 
The solution used for slice cutting and maintenance contained (in mM): NaCl 130, KCl 
3, NaH2PO4 1.5, CaCl2 1, MgCl2 5, NaHCO3 25, glucose 10 (pH 7.4 adjusted with NaOH; 
290-310 mOsm). 
 
2.2. VOLTAGE CLAMP RECORDINGS 
The extracellular solution used to perfuse slices during recording contained (in mM): 
NaCl 130, KCl 3, NaH2PO4 1.5, CaCl2 1.5, MgCl2 1, NaHCO3 25, glucose 15 (pH 7.4 with 
NaOH, 300-320 mOsm). Patch pipettes were filled with intracellular solution containing 
(in mM): CsCl 130, NaCl 5, MgCl2 2, CaCl2 1, HEPES 10, BAPTA 10, ATP-Mg 2, sucrose 
2 (pH 7.2 with CsOH; 280-300 mOsm).   
 
2.3. DRUG APPLICATION 
Drugs were applied in two different ways: either bath-applied via the extracellular 
solution superfused at 2-3 ml/min (for a minimum of 5-10 min to reach apparent 
equilibrium conditions), or via fast, focal pressure pulses. For the latter method, a thin-
walled glass micropipette was pulled in the same way as a patch pipette using a two-
stage puller (3P-A, List Medical, Germany) in order to obtain a DC resistance of 5-6 MΩ. 
The pipette was filled with nicotine (diluted to the final concentration of 2 mM in the 
external recording solution), and positioned approximately 20-50 µm away from the 
soma of the recorded cell, under microscopic control. The puffer pipette was connected 
to a Pneumatic Picopump (WPI, Sarasota, FL, USA); pulses duration ranged from 10 ms 
to 60 s (4-8 p.s.i. pressure). As long as applications were spaced at intervals of 1 min, 
observed responses were closely reproducible (see also Khiroug et al., 1998; Pagnotta et 
al., 2005).  
All experiments were performed in the continuous presence of bicuculline (10 µM) and 
strychnine (0.4 µM) in the bathing solution; these drugs were used as pharmacological 
 26 
tools to block GABA and glycine-mediated transmissions (Donato and Nistri, 2000; 
Marchetti et al., 2002). In this way glutamatergic transmission could be studied in 
isolation. 
The following drugs were used: 6-cyano-7nitroquinoxaline-2,3-dione (CNQX), D-
amino-phosphonovaleriate (APV) and methyllycaconitine citrate (MLA) purchased 
from Tocris; bicuculline methiodide (bicuculline), dihydro-β-erytroidine hydrobromide 
(DHβE), ethyl[m-hydroxyphenil]-dimethylammonium chloride (edrophonium), ([-]-1-
methyl-2-[3-pyridyl]pyrrolidine) hydrogen tartrate salt (nicotine) and strychnine 
hydrochloride (strychnine) from Sigma; tetrodotoxin (TTX) from Latoxan.  
 
 
3.  ELECTROPHYSIOLOGICAL  TECHNIQUES 
 
3.1. PATCH-CLAMP RECORDING 
Recordings were performed at room temperature. The conventional whole-cell patch 
clamp technique (Hamill et al., 1981) was employed. Briefly, a small heat-polished glass 
pipette, pulled from thin–walled borosilicate glass capillaries (Hingelberg, Germany) 
with a two-stage puller (3P-A, List Medical, Germany) to a DC resistance of 3-4.5 MΩ 
(opening diameter between 0.5 and 1 µm), was pressed against the cell membrane. 
Gentle suction, applied to the pipette interior, led to the formation of an electrical seal 
with resistance in the order of 2-10 GΩ (giga-seal). After the giga-seal formation, 
additional suction applied to the pipette interior led to the membrane rupture, and 
direct low resistance access to the cell interior. 
An L/M-EPC-7 patch-clamp Amplifier (List Medical, Germany) was used for voltage 
clamp experiments. Cells were clamped at -60, -65 mV holding potential (Vh), and series 
resistance (5-25 MΩ) was routinely monitored, without any compensation. Voltage 
pulse generation and data acquisition were performed with a PC using pClamp 8.1-9.2 
softwares (Axon Instruments Inc.). All recorded currents were filtered at 3 kHz and 
sampled at 5-10 kHz.  
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3.2. ELECTRICAL STIMULATION 
Glutamatergic postsynaptic currents were evoked by placing a single bipolar tungsten 
electrode in the dorso-lateral reticular formation (Fig. 12) to stimulate afferent 
interneurons to the hypoglossal nucleus (Borke et al., 1983; Cunningham and 
Sawchenko, 2000). Stimuli of variable intensity and duration (10-100 V, 0.02-0.2 ms) 
were delivered at 10 s intervals, and were selected in each experiment in order to elicit 
submaximal responses. Electrically evoked synaptic currents were recorded and stored 
in a PC as individual files and then averaged with pClamp 8.1-9.2 after discarding failed 
events.     
  
 
 
Fig. 12. Schematic representation of a brain stem slice. Puffer pipette approaching HMs on the 
left, patch pipette on the righ. The stimulating electrode is placed in the dorso-lateral medullary 
reticular formation (mrf). X, vagal nucleus; XII, hypoglossal nucleus; AP, area postrema; Cu, 
cuneate nucleus; EC, external cuneate nucleus; Gr, gracile nucleus; IO, inferior olive; LRN, 
lateralreticular nucleus; mlf, medial longitudinal fasciculus; NTS, nucleus of the tract solitarius; 
py, pyramidal tract; SNV, spinal nucleus of the trigeminal nucleus.  
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4.  DATA  ANALYSIS 
Continuous recordings of spontaneous activity were stored on magnetic tape and 
transferred to a PC after digitalization with an A/D converter (Digidata 1200).  
Cell input resistance (Rin) was calculated by measuring the current response to 5 or 10 
mV hyperpolarizing steps (from -60,-65 mV, holding potential), or from the slope of the 
linear part of the I-V relation obtained by applying a slowly rising voltage signal (ramp 
test: from –80 to +20 mV, 41.7 mV/s).  
Single postsynaptic currents were detected using AxoGraph 4.6 (Axon Instruments, 
Foster City, CA) and Clampfit 9.2 (Axon Instruments) softwares, while SigmaPlot 2001 
(Jandel Scientific, San Rafael, CA) software was used for linear regression analysis of 
experimental data.  
Results were quantified as means ± S.E.M., with “n” indicating the number of cells in 
which the experiment has been repeated. Statistical significance was assessed with the 
Student’s paired t-test, applied only to raw data, or with the Tukey-test and ANOVA 
for non-parametric values; according to convention, two groups of data were 
considered statistically different if P<0.05. 
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RESULTS 
 
The database of the present study comprises 178 HMs, with 281±30 MΩ mean input 
resistance. 
 
 
1. INVESTIGATING THE PRESENCE OF TONIC CHOLINERGIC 
ACTIVITY  IN  THE  BRAINSTEM  SLICE  PREPARATION 
Previous studies have indicated that the nucleus hypoglossus expresses neuronal 
nAChRs (Zaninetti et al., 1999; Chamberlin et al., 2002; Dehkordi et al., 2005) and it is 
contacted by cholinergic fibers (Gilmor et al., 1996; Arvidsson et al., 1997; Schäfer et al., 
1998; Ferreira et al., 2001). In this study I first explored whether it was possible to 
observe direct cholinergic network activity on HMs, using a simple brainstem slice 
preparation. I started recording spontaneous synaptic currents (sPSCs) from HMs. 
Bicuculline and strychnine were routinely added to the recording solution, in order to 
block synaptic inhibitory processes (Donato and Nistri, 2000); the remaining activity 
was considered to be mediated by glutamate (Sharifullina et al., 2004, 2005) (Fig. 13A, 
top trace). Then the ionotropic glutamate receptor antagonists, CNQX (10 M) and APV 
(30 M), were bath-applied to reveal any non-glutamatergic excitatory currents (Fig. 
13A, middle traces): however, no events could be detected, confirming that spontaneous 
events were glutamatergic. This observation suggests the lack of spontaneously active 
cholinergic synapses on HMs (n=6), at least in this preparation.  
I also wondered if blocking ACh hydrolysis, with the cholinesterase inhibitor 
edrophonium (20 M), could boost ACh availability and unmask cholinergic events 
(Kouznetsova and Nistri, 2000). However, as shown in Fig. 13A (bottom traces), even in 
this case there was lack of synaptic activity when CNQX and APV were present (n=3 
cells).  There  was  also  no  change   in  baseline  current.  Because  lack  of  spontaneous  
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Fig.13. Lack of endogenous cholinergic activity on HMs. (A) Upper traces: consecutive 
recording from a voltage clamped motoneuron (in the presence of 10 M bicuculline and 0.4 M 
strychnine. Middle traces: no residual activity is detectable after the application of APV (30 M) 
and CNQX (10 M)(n=6). Bottom traces: addition to the bathing solution of the AChE inhibitor 
edrophonium (20 M) is ineffective to disclose any endogenous and spontaneous release of 
ACh (n=3). Reproduced traces are representative of the same cell. (B) ePSCs elicited by sub-
maximal stimulation of the dorso-lateral mrf (see methods): average traces of 20 pulses (10 Hz 
train) recorded in control solution, or in the presence of glutamatergic transmission blockers, 
alone and together with edrophonium (20 M). Same cell as in (A). 
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cholinergic events might have suggested low release probability, it was attempted to 
elicit cholinergic currents by stimulating the reticular formation (mrf) with 10 Hz trains. 
Under these conditions and using a protocol which produces monosynaptic 
glutamatergic currents (Essin et al., 2002; Sharifullina et al., 2004), confirmed by the 
relatively short and constant lantency (4.8 ±0.3 ms, n=13) of the currents, I could record 
robust electrically evoked postsynaptic currents (ePSCs; Fig. 13B, left). These responses 
were fully suppressed in the presence of CNQX plus APV (Fig. 13B, middle; n=3), 
confirming that them to be primarily glutamatergic. No other evoked activity could be 
recorded, in the presence of glutamatergic ionotropic receptor blockers, even after 
applying edrophonium (Fig. 13B, right; n=3).  
However, interestingly, glutamatergic spontaneous transmission resulted significantly 
depressed following edrophonium application (about 4 min from the start; Fig. 14A).  
This effect consisted in a significant reduction in event frequency without change in 
event amplitude (Fig. 14B), and was reversible on washout (not shown). 
 
 
 
 
 
Fig.14. Edrophonium indirect effect on spontaneous glutamatergic transmission. (A) Sample 
of glutamatergic sPSCs recorded before and during bath-application of 20 M edrophonium 
(upper and lower traces, respectively). (B) Histograms showing the resulting effect of 
edrophonium: 20M edrophonium significantly reduces the frequency of sPSCs to 52.8 ±9 % 
(n=9, p<0.05) of control value, while leaves unchanged their peak amplitude (99.8 ±4 %, n=9). 
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Overall, spontaneous transmission is made up of network dependent and network 
independent events. To isolate synaptic terminal activity, recordings are usually 
performed in the presence of TTX (1 M). In these conditions it was possible to record 
miniature glutamatergic synaptic events (mPSCs), which were unaffected in their 
frequency and amplitude by edrophonium (N. Lamanauskas, personal 
communication). Thus, the changes in glutamatergic activity observed during 
edrophonium application, were the consequence of enhanced cholinergic activity at 
network level rather than at presynaptic sites. 
 
 
2. EFFECTS OF NACHR ANTAGONISTS ON GLUTAMATERGIC 
CURRENTS 
High concentrations of di-hydro-β-erythroidine (DHβE) are commonly used for broad 
spectrum, non-selective antagonism of nAChRs (see review by Dwoskin and Crooks, 
2001). Bath application of 200 M DHβE reduced the peak amplitude of glutamatergic 
sPSCs and ePSCs recorded from HMs (Fig. 15A, B), without significantly changing 
either the current kinetics (Fig. 15B) or the frequency of sPSCs (Fig. 15 C). Baseline 
current was unaffected. 
On the other hand, submicromolar concentrations of DHβE possess strong selectivity 
towards the α4β2 nAChR subtype (Harvey and Luetje, 1996). Because α4β2 receptors 
are widely expressed in the brainstem (Zaninetti et al., 1999), I tested whether DHβE, at 
0.5 M concentration, was still able to modify glutamatergic currents. Fig. 16A shows 
that, at this concentration, DHβE significantly depressed the peak amplitude of sPSCs 
(see also histograms in Fig. 16D). Analogous observations were obtained when 
examining the action of 0.5 M DHβE on mPSCs (Fig. 16B, D) and ePSCs (Fig. 16C, D). 
The right panel of Fig. 16 shows that, after scaling and superimposing, ePSCs retained 
similar kinetics. No significant change was observed in terms of event frequency either 
for sPSCs or mPSCs (Fig. 16D). It is noteworthy that the peak amplitude reductions in 
the presence of 0.5 M DHβE were quantitatively smaller than those achieved with 200  
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Fig.15. Effect of a massive blockage of nAChRs, on glutamatergic transmission. (A) 
Recordings of sPSCs in control condition (bicuculline and strychnine in the bath, see methods), 
and in the presence of 200 M DHβE (right). Data from the same cell. (B) Seventeen 
superimposed ePSCs (0.1 Hz; black traces) with their average (coloured trace) were collected in 
control condition (left) and in the presence of DHβE (middle). Synaptic failures have been 
omitted. Averaged traces normalized and superimposed show no changes in the kinetics of 
glutamatergic ePSCs (right). (C) Summary of the effect of 200 M DHβE on glutamatergic 
transmission: the peak amplitude of both sPSCs and ePSCs resulted substantially depressed to 
72.9 ±6 % (n=9, p<0.02) and 71.0 ±4 % (n=7, p<0.002), respectively. On the contrary, the 
frequency of sPSC is not affected (113.4 ±13 %, n=9). 
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Fig.16. Effect of 0.5 M DHβE on glutamatergic transmission.  (A) Effect of DHβE on 
glutamatergic sPSCs (right), compared to control condition (left). (B) Glutamatergic mPSCs 
isolated in the presence of 1 M TTX (left), and their responsiveness to the application of DHβE 
(right). (C) Superimposed glutamatergic ePSCs (0.1 Hz stimulation) recorded in control solution 
(left, nine traces) and in the presence of DHβE (center, twelve traces); their relative averages, 
shown in coloured line, are normalized and superimposed (right). (D) Histogram summarizes 
the effect of 0.5 M DHβE on glutamatergic transmission: sPSCs, mPSCs and ePSCs resulted all 
reduced in peak amplitude (83.4 ±5 %, 85.8 ±4 % and 77.3 ±7 % of control values, respectively; n 
 5, p<0.05). However neither sPSCs nor mPSCs appeared significantly changed in their 
frequency (90.5 ±10 % and 92.8± 6 %, respectively). 
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Fig.17. Effect of 5 nM MLA on glutamatergic transmission. (A) Continuous recordings of 
glutamatergic activity in control (left panel), and after the application of MLA (right panel). (B) 
mPSCs recorded in control solution and in the presence of 5 nM MLA. (C) Superimposed ePSCs 
(0.1 Hz) recorded in control (left, eleven traces) and in MLA containing solution (middle, nine 
traces); their relative averages (coloured) are normalized and superimposed (right). (D) 
Histogram summarize the effect of 5 nM MLA on glutamatergic transmission: there is a 
significant depression of the peak amplitude of sPSCs (86.4 ±3 %, n=15, p0.001), mPSCs (84 ±5 
%, n=6, p<0.05) and ePSCs (76.7 ±4 %, n=7, p0.0001), with no change on sPSCs (114.9 ±20%) 
and mPSCs (89 ±10 %) frequencies. 
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M DHβE. This result suggests that other nAChR subtypes might have contributed to 
the regulation of glutamatergic currents. 
Because α7 receptor subunits are expressed within the rat brainstem (Zaninetti et al., 
1999; E. Fabbretti and N. Lamanauskas, unpublished), I tested the action of the alkaloid 
MLA, one of the most potent and selective antagonist at the α7-homomeric nAChR 
subtype (Palma et al., 1996; Bergmeier et al., 1999; Davies et al., 1999; Jones et al., 1999). 
At the concentration of 5 nM, MLA significantly reduced the peak amplitude of both 
sPSCs, mPSCs and ePSCs (Fig. 17A-D), without changing either ePSC kinetics (right 
panel of Fig. 17C, after scaling and superimposing average traces) or sPSCs and mPSCs 
frequency. I have also tested larger doses of MLA; up to 10 nM, no further reduction in 
synaptic response amplitude could be observed (data not shown). 
 
 
3. FUNCTIONAL PROPERTIES OF NACHR S ON HMS  
Lack of direct cholinergic synaptic activity on HMs did not preclude the possibility that 
HMs expressed functional nAChRs. To examine this issue and to minimize problems 
due to hydrolysis of ACh by AChE and to nAChR desensitization, I applied nicotine to 
voltage-clamped hypoglossal motoneurons, by means of brief pressure pulses (4-10 psi) 
delivered through a puffer pipette positioned 20-50 µm far from the soma of the cell (see 
also Di Angelantonio and Nistri, 2001; Pagnotta et al., 2005). Pressure ejected nicotine 
was able to generate fast post-synaptic inward currents in the patched cell. The peak 
amplitude of those currents was directly related to the duration of the pulse, so that 
increasing the delivery time of nicotine produced increasingly larger inward currents 
(Fig. 18A, left), because of the larger doses administered. The threshold to get a 
response to nicotine was at 10 ms, while amplitude saturation was gained with 
applications lasting approximately 500 ms (Fig. 18A, right). The half-maximal response 
was calculated to be reached with 160 ms long pulses.  
Nicotine-induced inward currents  persisted  in   the  presence of  CNQX  and  APV 
(Fig. 18 Ba;  n=7),   indicating   they   were   not    generated    by     glutamate     released    
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from presynaptically activated terminals. In fact, 100 M DHβE was able to fully 
suppress them (Fig. 18Bb; n=3). Responses to puffer application of nicotine for up to 1 s 
were not accompanied by changes in sPSCs, showing that a relatively short puffer 
application of this drug predominantly affected HMs rather than network neurons.  
 
 
 
 
 
Fig.18. Nicotine generates fast inward currents on HMs. (A) Left: sample of responses to 50, 
100, 200, 500 or 1000 ms long pulses of pressure-ejected nicotine. Right: the plot shows the 
relationship between the normalized peak amplitude of responses (∆IN) and the duration of the 
puffer pulse (normalization is carried out with respect to 100 ms pulse response, n 5). (B) 
Inward currents generated by nicotine (75 ms) are insensitive to bath application of APV (30 
M) plus CNQX (10 M, n=6), while are completely antagonized by 100 M DHβE (n=3). 
 
 
For pharmacological identification of the nAChR subtypes mediating HM responses to 
nicotine, DHβE and MLA were again used, at subtype selective concentrations. Fig. 19A  
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indicates that  0.5 M DHβE  reduced responses at all tested doses of nicotine. Likewise, 
a similar decrease was obtained in the presence of 5 nM MLA (Fig. 19B). When DHβE 
and MLA were co-applied, the summative action resulted in an almost complete 
blockage of the nicotine induced current (Fig. 19C). 
 
 
 
 
Fig.19. Pharmacological characterization of the nicotine induced inward currents. 
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4. DESENSITIZATION OF NACHR S ON HMS 
To investigate the time constant of nAChR desensitization onset I delivered long pulses 
of nicotine, in analogy to the protocol used by Katz and Thesleff (1957). HMs responded 
to such puffer pulses generating inward currents, which peaked and faded back to 
baseline even though the pulse had not ceased yet, as shown in Fig. 20A.  The decay of 
such currents could be fitted by a mono-exponential time constant (τ) of 211 ±35 ms 
(n=6). The time necessary for recovering from desensitization was investigated with the 
paired pulse protocol stimulation: two nicotine puffer pulses of the same duration (50 
ms) were delivered at increasing time intervals (Katz and Thesleff, 1957). Recovery was 
considered complete when response to the second, test pulse reached the same peak 
amplitude of the first, conditioning pulse (Fig. 20B, left). Full receptors functionality 
was stably regained with a 60 s long interval between the two consecutive pulses (Fig. 
20B, right). 
 
Receptor desensitization also occurred in the presence of sustained (4-5 min) bath-
application of small concentrations (0.1-1 M) of nicotine. These nicotine 
administrations, in 20 out of 55 cells, generated an inward current which on average 
shift was calculated to be -56 pA. This macroscopic inward current started fading after 
about 1 min from its peak. Notwithstanding the ability of bath-applied nicotine to 
induce direct HM responses, the effects of subsequent test pulses of nicotine were 
always strongly attenuated (Fig. 20C). For instance, the currents elicited by 100 ms 
nicotine pulses were reduced in the presence of 0.5 M nicotine to 17.6 ± 4.6 % of 
control ones (n=5). 
 
 
Ctd from Fig.19.(A) Left: example of the effect of 0.5 M DHβE on responses produced by brief 
pulses of nicotine (100ms). Right: dose/response curves representative of control and DHβE 
enriched medium (n=9). (B) Samples representative of the effect of 5 nM MLA on nicotine 
generated current, different cells than in (A) Plots of responses to puffer applications of nicotine 
in control and MLA containing solution (n=10; right). (C) Application of both antagonists 
resulted in an almost complete blockage of the nicotinic currents (n=9, for right hand side plot). 
All data are normalized to value of the response to a 100ms pulse, relative to each data set. 
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Fig.20. Desensitization affects responsiveness of nAChRs to nicotine. (A) During 1 s long 
nicotine pulse application the resulting inward current peaks and then decays 
monoexponentially (average time constant=211 ±35 ms; n=6; vertical dot bars indicate the 
record used for fitting). (B) Time necessary for recovering from desensitization was investigated 
with the paired pulse protocol stimulation, where two identical nicotine pulses (50 ms) are 
delivered at increasing time intervals (4, 8, 16, 32, 64, 90, 120 s). The graph on the right shows 
the relative amplitude of the second response (as % of the first one) plotted against the inter-
pulse interval; complete recovery is regained after about 60 s (n=3). (C) Sample traces showing 
how currents generated by focally pulsed nicotine (100 ms) are strongly depressed during bath-
applied 0.5 M nicotine. The plot on the right summarizes the depressive effect of bathing 
nicotine (n 3); values are normalized with respect to the response to 100 ms pulse. 
 
 
Then I wished to examine if network nAChRs controlling glutamatergic transmission 
were equally subjected to desensitization. I tested how a much longer application of  
nicotine,   supposed   to  strongly  activate  nAChRs,  could  modulate  glutamatergic 
currents. For this purpose, I applied a long (1 min) puffer pulse of nicotine (in excess of 
the one eliciting the maximal response, cf. Fig. 18A) and measured both amplitude and 
frequency of glutamatergic sPSCs. Data were collected before the start of the puffer 
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administration and after the inward current  elicited  by  nicotine had  subsided  due  to 
nAChR desensitization, as shown in Fig. 21A. Under these circumstances, there was a 
significant fall in the sPSC average frequency (analogous to the one found with a small 
dose of nicotine), plus a significant reduction in sPSC average amplitude (Fig. 21B, n=6).  
 
 
 
 
 
Fig.21. Effect of an acute administration of nicotine on glutamatergic transmission. (A) Top: 
continuous recording of glutamatergic sPSCs before and during the application (1 min) of 
nicotine via a puffer pipette. Insets: two fragments runned at a faster time scale. (B) Histograms 
summarizing the effect of nicotine on sPSCs: both peak amplitude and frequency resulted 
depressed during nicotine pulse to 80.1 ±4 % and 51.4 ±8 % of control, respectively (n=7, 
p<0.01). 
 
 
Afterwards I investigated the effect of a long lasting application of nicotine on 
glutamatergic transmission, using a dose closer to those observed in the brain of 
smokers, namely 0.5 M. After 5-6 min of such nicotine bath-application, the frequency 
of both sPSCs and mPSCs resulted reduced, but no significant changes were observed 
in  their  amplitude  (Fig.  22A, B, D).  
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Fig.22. Effect of a low dose of nicotine on spontaneous glutamatergic transmission. (A) 
Continuous recordings of glutamatergic sPSCs in control condition or in the presence of 0.5 M 
bathing nicotine. (B) Continuous  recordings  of mPSCs  in control or in the  presence of  0.5 M 
nicotine. (C) Example of amplitude distribution histogram for mPSCs. Events are clustered 
between –8 and –15 pA, even in the presence of nicotine. (D) Indeed 0.5 M nicotine does not 
affect the peak amplitude of neither sPSCs or mPSCs (99.6 ±3% and 100.4 ±6 % of control value, 
respectively, n=7), . but it significantly decreases their frequency, resulting 52.1 ±7 % (n=7, 
p<0.01) and 69.1 ±8 % (n=7, p<0.03), respectively. 
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Experiments on glutamatergic ePSCs provided additional clues about the sensitivity of 
brainstem nAChRs to desensitize in the presence of submicromolar doses of nicotine. In 
fact, as indicated in Fig. 23A, after about 4 min in the presence of 0.5 µM nicotine ePSCs 
were depressed without changing their kinetics. Network transmission was deeply 
impaired as the number of failures increased significantly (Fig. 23B). It was interesting 
to observe that the smaller ePSCs amplitude (calculated after excluding failures) 
displayed much smaller fluctuations as indicated by their CV value (Fig. 23C). The 
input/output curve obtained plotting the ePSC amplitudes as a fraction of their 
maximum versus the stimulus intensity resulted flattened in the presence of nicotine. 
The strongest depression was observed for responses elicited by the higher intensity 
stimuli (Fig. 23D). 
 
 
 
 Fig.23. Effect of 0.5 M nicotine on glutamatergic ePSCs. 
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In view of the diffuse distribution of glutamatergic afferents to HMs, only part of which 
were electrically stimulated, and their association with nAChRs, it seemed interesting to 
compare the dynamics of depression of ePSCs and sPSCs (Fig. 24). So I measured ePSC 
amplitude following continuous 0.1 Hz stimulation before and following bath-
application of 0.5 M nicotine (Fig. 24A, left; n=8): there was a transient, early 
facilitation of ePSC amplitude which lasted for about 100 s (p<0.05, Tukey test), 
followed by a significant depression (p<0.05) which outlasted the nicotine 
administration. On average, the facilitation was 136 ±8 % versus the average control 
amplitude, while the depression amounted to 53 ±5 %. To obtain recovery from 
nicotine-evoked depression a 5 min long wash-out was necessary. Surprisingly, when 
an even lower (0.1 M) concentration of nicotine was used (see Fig. 24A, right), ePSCs 
were just reduced in amplitude, a phenomenon developing about 2 min from the switch 
to the nicotine containing solution. The largest reduction in current response (52 ±4 % of 
control, n=7) was comparable to the one observed during exposure to 0.5 M nicotine. 
On the other hand, sPSCs displayed a different sensitivity to bath-application of 
submicromolar concentrations of nicotine. In particular, as indicated in Fig. 24B, neither 
0.5 (left panel) nor 0.1 M  nicotine  (right  panel)  altered  the  peak  amplitude of  these 
currents although both doses facilitated sPSC frequency with dissimilar timecourse. 
With 0.5 M nicotine the frequency facilitation (525 ±48 % of control; n=5) peaked at 
about 2 min and then gradually  declined  back to  baseline.  With 0.1 M nicotine  the 
frequency facilitation (242 ±5 %; n=8) of sPSCs was clearly delayed with development 
after >4 min from the start of application.    
 
 
Ctd from Fig.23. (A) Ten superimposed glutamatergic ePSCs (black lines) elicited by sub-
maximal stimulation of the mrf (0.1Hz), in control solution and after addition of 0.5 M nicotine 
(averages are in coloured line). Failures are not shown, but they resulted increased in number 
(B): 52.7 ±10 % in nicotine containing medium, versus 20 ±4 % of total responses in control 
medium (n=9, p<0.01). (C) Nicotine strongly depresses synaptic transmission, decreasing the 
mean peak amplitude of ePSCs (60.3 ±7 % of control; n=8, p<0.02), and reducing the CV of 
response amplitude  (75 ±6 % of control; n=7, p<0.02). (D) In the input-output curves, build up 
normalizing ePSC peak amplitude to their maximum (∆IN), asterisks indicate a significant 
difference between responses collected in control solution and those recorded in the presence of 
0.5 M nicotine (p<0.05, with  Tukey test; n4). 
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Fig.24. Timecourse of the action of bath-applied nicotine on glutamatergic transmission. (A) 
Timecourses of the effect of 0.5 (left, n=8) and 0.1 (right, n=7) M nicotine on glutamatergic 
ePSCs. Shaded areas indicate the time window relative to nicotine application. Values are 
normalized with respect to the mean of those recorded before the application of nicotine.  
Asterisks indicate the datapoints which are signficantly different (p<0.05, Tukey test) from 
control. (B) Timecourses of the effect of 0.5 (left, n=5) and 0.1 (right, n=8) M nicotine on 
glutamatergic sPSCs (black dots, peak amplitude; gray dots, frequency). Frequency values were 
obtained by analyzing 20 s segments of consecutive records. All values are normalized to 
control ones. To avoid potential interference due to cumulative desensitization, cells were tested 
with one dose only of bath-applied nicotine.  
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5. IMMUNOHISTOCHEMISTRY OF NACHR S IN BRAINSTEM SLICES 
Molecular biology experiments, performed in our laboratory by E. Fabbretti and N. 
Lamanauskas, provided further evidence in confirmation of the above reported 
electrophysiological findings.  
As shown in Fig. 25A, within the nucleus hypoglossus, immunoreactive cell bodies, cell 
processes and fibers were intensely labeled with anti-α4, α7 and β2 antibodies. In 
general, immunoreactive cells appeared to be more numerous in the caudal end than in 
the rostral end of the nucleus. In each histological slide the number of motoneurons (20-
40 µm somatic diameter) immunoreactive for any nAChR subunit has been counted and 
divided by the area of the nucleus hypoglossus in same slide (Fig. 25B). The density of 
neurons immunoreactive to α4, α7 or β2 resulted to be very similar.  
Anti-α4, α7 and β2 antibody specificity was evaluated performing western 
immunoblotting experiments, using lysates derived from P3 rat brainstem. As shown in 
Fig. 25C (lanes b), single immunoreactive bands corresponding to the expected 
molecular weights of the rat α4, α7, or β2 nAChR subunits were observed. In particular, 
the anti-α4 antibody recognized a band of 70 kDa, the anti-α7 highlighted a band of 57 
kDa, and the anti-β2 antibody gave a band at approximately 50 kDa, in full agreements 
with previous studies performed on rat brain tissue (Arroyo-Jiménez et al., 1999; Jones et 
al., 2001; De Simone et al., 2005). Western blots of comparable amount of protein extracts 
from rat kidney were used as negative control, showing no detectable signal (Fig. 25C, 
lanes c).  
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Fig.25. Immunohistochemistry of nAChRs in the nucleus hypoglossus. (A) Immunostaining 
of brainstem slices (x10 and x20 magnification for top and bottom rows, respectively) with 
antibodies against α4, α7 or β2 nAChR subunits reveals reactivity in HMs. (Scale bar=100 m). 
(B) Bar charts of the density of immunoreactive cells in the hypoglossal nucleus for each type of 
nAChR subunit. (C) Western immunoblot of α4, α7 or β2 nAChR subunits. Lane “b” refers to 
brainstem samples while lane “c “ refers to kidney samples used as negative control. 
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DISCUSSION 
 
  
1. USE OF HMS TO INVESTIGATE MODULATION OF EXCITATORY 
SYNAPTIC TRANSMISSION 
Previous reports have demonstrated the usefulness of recording from HMs to 
investigate the neuronal properties of integrated input signals (Bellingham and Berger, 
1996; Rekling et al., 2000). Moreover, it has been shown how the efficiency of excitatory 
or inhibitory synaptic transmission could be modulated by activation of certain receptor 
populations. For instance, activation of metabotropic glutamate receptors is known to 
facilitate glutamatergic transmission and to constrain HMs into an oscillatory pattern 
(Sharifullina et al., 2004, 2005). Recently, we have observed that muscarinic receptors for 
ACh strongly depress inhibitory neurotransmission mediated by glycine or GABA 
(Pagnotta et al., 2005), while they facilitate glutamatergic transmission (Bellingham and 
Berger, 1996). 
Recent experiments have indicated that HMs possess functional nAChRs (Chamberlin 
et al., 2002). Furthermore, within the brainstem network impinging upon HMs, there are 
nAChRs that appear to upregulate the activity of inspiratory interneurons projecting 
glutamatergic inputs to HMs (Shao and Feldman, 2005). Hence, rat HMs offer the 
special advantage of studying both network and postsynaptic nAChRs in the same 
preparation. 
Nevertheless, it is unclear if nAChRs can actually modulate glutamatergic synaptic 
transmission directly on HMs and whether such effects can be functionally 
distinguishable from those due to activation of postsynaptic nAChRs of HMs. In fact, 
although it is clearly established that one important action of nAChRs on mammalian 
brain neurons is to favour the release of the excitatory transmitter glutamate (McGehee 
et al., 1995; Gray et al., 1996; Wonnacott, 1997; Mansvelder and McGehee, 2000; Genzen 
and McGehee, 2003; Ge and Dani, 2005; Guo et al., 2005), it remains to be ascertained the 
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relative contribution of pre and postsynaptic nAChRs to HM activity mediated by 
glutamate. 
For these reasons the present study was focused on the functional and pharmacological 
properties of nAChRs, and in particular on how nAChRs can modulate glutamatergic 
transmission, their locus of action, and sensitivity to nicotine, so mimicking any 
potential changes in HM activity induced by exposure to tobacco smoke.  
 
 
2. NACHR S EXPRESSED BY HMS   
HM nAChRs could be rapidly activated by focal application of nicotine, generating 
inward currents insensitive to glutamate, glycine and GABA receptor blockers. 
Although a previous report cast doubt on the expression of α7 receptors by HMs 
(Chamberlin et al., 2002), recent immunocytochemical data, confirmed in our laboratory, 
support the expression of both α4, α7 and β2 subunits by HMs (Dehkordi et al., 2005). 
Moreover, the present study demonstrates that they are also functionally active.  
The pharmacological profile of HM nAChRs was investigated using specific 
antagonists, namely DHβE and MLA, in subtype selective doses. Their combined 
application generated virtually full suppression of nicotine-induced responses, 
suggesting that the vast majority of nAChRs on motoneurons comprised homomeric α7 
and heteromeric α4β2 receptors, in analogy with most other mammalian brain regions 
(Gotti and Clementi, 2004). 
 
 
3. ARE NATIVE NACHR S ENDOGENOUSLY ACTIVATED? 
The brain slice technique facilitates investigations of synaptic transmission, because it 
preserves both healthy neurons and good connections, overcoming other technical 
troubles encountered in “in vivo” experiments, such as mechanical instability, and 
difficulties in modifying the extracellular environment. 
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Anyway, it should also be acknowledged that the brain slice preparation is not ideally 
suited to demonstrate the role of projection neurons: connections are preserved only to 
a certain extent, because of the unavoidable injury occurring during slicing. The size of 
the network contributing to a certain physiological function results inevitably limited, 
but at the same time, the simplified circuitry helps understanding certain basic 
mechanisms under investigation. This condition thus enables to formulate theories to be 
confirmed with “in vivo” experiments. 
These limitations, intrinsic to the use of brain slices, probably are the explanation for the 
impossibility of observing any random release of ACh, in the presence of blockers of 
glutamate, GABAA and glycine receptors, i.e. no spontaneous or electrically evoked 
synaptic events could be detected. Even following inhibition of AChE activity with 
edrophonium, there was no unmasking of cholinergic events. These observations 
suggest that cholinergic synapses on HMs were sparse and/or with low release 
probability (note lack of cholinergic miniature events).  Thus, in the slice preparation, 
cholinergic terminals on HMs (Gilmor et al., 1996; Arvidsson et al., 1997; Schäfer et al., 
1998; Ferreira et al., 2001) had little functional impact on motoneuron membrane 
properties. It is possible that such projections may require activation by direct 
stimulation of neurons located outside the slice preparation. This hypothesis will 
require future experiments with “in vivo” preparations. 
 
However, the administration of edrophonium, to boost endogenous ACh levels, 
significantly reduced the frequency of glutamatergic sPSCs. Because this effect was 
absent in TTX solution, it probably took place at network level. Actually the effect of 
edrophonium application appears to be complex. In fact, raised ACh concentrations, 
beside activation and desensitization of nAChRs on glutamatergic premotoneurons, 
would be expected to activate muscarinic receptors as well, which can modulate HMs 
excitability (Shao and Feldman, 2000; Pagnotta et al., 2005).  
To simplify the resolution of this issue, rather than enhancing the concentration of 
endogenous ACh to study its potential action on glutamatergic transmission, I 
investigated whether blocking nAChRs with selective antagonists could help to reveal 
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any discrete change in excitatory synaptic transmission. It is noteworthy that the 
nicotinic antagonists used in the present study do not have non-selective actions on 
glutamate AMPA receptors (Alkondon et al., 1999; Santos et al., 2002). 
Application of a large dose of DHβE to antagonize the entire population of nAChRs 
decreased the amplitude of sPSCs and ePSCs. Similar, though less intense, effects were 
also found with submicromolar concentrations of DHβE (to selective inhibit the β2 
subunit containing receptor subpopulation), or MLA (to antagonize the α7 subtype). 
Adding up the inhibition produced by each antagonist gave an effect analogous to the 
one produced by a non-selective, large dose of DHβE, indicating that nAChRs 
controlling glutamatergic transmission probably belonged to those two receptor 
subtypes. Their location presumably included some glutamatergic terminals (in view of 
the fact that the size of mPSCs were reduced by such antagonists), as well as network 
premotoneurons.  
Although the precise location of such nAChRs within the brainstem network remains 
still incompletely understood, it is worth considering the possibility that some of them 
were expressed at the level of projecting axons to regulate spike activity and hence 
transmitter release.  
In summary then, the present data suggest a significant contribution by nAChRs 
activated by endogenous ACh to glutamatergic transmission on HMs in the present 
experimental model. Although the multiplicity of glutamatergic synapses and their 
releasing sites make it difficult to perform a quantal analysis of excitatory synaptic 
transmission, further complexity may originate from the role of nAChRs at such 
synapses, thus determining quantal parameters at various sites.  
 
It was somewhat surprising to observe that nAChR blockers decreased the amplitude of 
mPSCs (beside sPSCs and ePSCs) without affecting their frequency. Previous studies 
have shown that, on rat HMs, such events are mediated by AMPA receptors (Essin et 
al., 2002; Sharifullina et al., 2004). At mammalian central synapses the amplitude of 
mPSCs depends on pre and postsynaptic factors. In the case of glutamatergic synapses, 
although co-activation of nAChRs and AMPA receptors can synergistically excite 
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interneurons (Alkondon et al., 2003), there is no evidence for a fast, direct cross-
interaction between these classes of ionotropic receptors on the postsynaptic membrane. 
It seems therefore more probable that nAChR activity can facilitate glutamatergic 
transmission presynaptically. Because nAChR activation mediates influx of Ca2+ at 
presynaptic level (Dajas-Bailador and Wonnacott, 2004), one possibility is that 
augmented levels of this divalent cations led to release of larger pools of glutamate 
(Voronin, 1993, 1994; Llano et al., 2000). Reducing the nAChR contribution with 
selective antagonists might therefore desynchronized vesicle release so that the 
amplitude of the postsynaptically recorded events was correspondingly decreased. 
Indeed, Sharma and Vijayaraghavan (2003) have suggested that nAChR activity 
strongly contribute to the amount of glutamate released at individual synapses of the 
rat hippocampus. 
 
 
4. DESENSITIZATION OF NACHR S ON HMS    
Currents generated by HMs, in response to focal application of nicotine, showed a 
relatively fast desensitization which developed with a time constant of approximately 
200 ms. Anyway, recovery occurred promptly upon nicotine washout, indicating that 
nAChRs could rapidly respond to changes in agonist concentrations. 
In accordance with the pioneering work by Katz and Thesleff (1957) on the frog 
neuromuscular junction, I also observed that, on HMs, even bath application of low 
concentrations of nicotine largely desensitized the currents generated by brief puffer-
delivery of nicotine. For these experiments I used bath concentrations of nicotine 
comparable to those found in the plasma of smokers (Gotti and Clementi, 2004). 
Interestingly, such concentrations of nicotine elicited a transient inward current in a 
minority of cells only, leaving a residual ability of the HM membrane to respond (albeit 
with significantly smaller amplitude) to focal application of large concentrations of 
nicotine. This finding can be related to the existence of multiple desensitized states  
with differential agonist sensitivity (Giniatullin et al., 2005). 
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Administration of nicotine also affected glutamatergic transmission. In fact, a large dose 
of this drug strongly (and reversibly) decreased the amplitude and frequency of sPSCs 
as expected as a consequence of full desensitization of nAChRs at prejunctional level. 
However, smaller (sub-micromolar) concentrations of bath-applied nicotine induced 
more complex effects on synaptic transmission. On the one hand, the frequency of 
sPSCs and mPSCs was significantly reduced with no loss in amplitude; on the other 
hand, ePSCs were depressed, their amplitude fluctuations minimized, and the number 
of failures increased. It seems likely that these effects originated from broad activation 
and subsequent desensitization of nAChRs at network and presynaptic level. To clarify 
this issue, I analyzed the dynamics of changes in synaptic transmission after applying 
very low doses of nicotine, monitoring both sPCSs and ePSCs. As far as sPSCs were 
concerned, there was a transient facilitation of synaptic event frequency (without any 
change in event amplitude) whose occurrence was related to the dose of nicotine. The 
amplitude of ePSCs was transiently enhanced by 0.5 M nicotine and subsequently 
depressed, whereas 0.1 M nicotine consistently decreased the ePSC size. 
It is noteworthy that, also in the case of metabotropic glutamate receptor activation, 
there is a differential modulation of spontaneous and electrically evoked events which 
is accounted for by assuming dissimilar receptor distribution (Sharifullina et al., 2004). 
In analogy with this result, the present data obtained with nicotine could be explained 
by assuming a differential distribution of nAChRs between neurons stimulated 
electrically and those spontaneously active. On spontaneously active cells, low doses of 
nicotine first facilitated event frequency, suggesting initial enhancement of glutamate 
release. Lack of change in event amplitude argues against a direct interaction between 
nAChRs activated by nicotine and glutamatergic receptors on the HM membrane. On 
neurons stimulated electrically, nAChRs were more susceptible to desensitization, 
which arose rapidly after activation (with increased response amplitude) causing 
subsequent depression. Very small concentrations (0.1 M) of nicotine could actually 
induce synaptic depression with no evidence for prior facilitation, probably because 
nAChRs can be desensitized without being activated at low agonist concentrations 
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(Paradiso and Steinbach, 2003). This phenomenon is termed “high affinity 
desensitization” (Giniatullin et al., 2005) and, when occurring with ambient ACh, it can 
shape synaptic transmission efficacy (Lester, 2004).  
 
 
5. A SCHEME TO ACCOUNT FOR THE EFFECTS OF NACHR ACTIVITY 
ON HMS EXCITABILITY  
The complexity of the observed effects with agonist and antagonist applications is not 
easily resolved, even working on a reduced brain preparation. To aid future 
experiments targeted at clarifying the precise mode of action of nAChRs, it might, 
however, be useful to devise a simple scheme, as shown in Fig. 26, which is built on the 
reported experimental observations with the purpose of combining all available data 
into a unifying hypothesis. 
Since there was close analogy in the functional consequence of applying either α7 or β2 
subunit blockers and it was found analogous immunohistochemical expression of these 
subunits, it seems likely that α7 and α4β2 receptors shared similar distribution and 
function at network and HM level. When selective nicotinic blockers were applied in 
the absence of an agonist like nicotine, their effect would be manifested only where 
endogenously released ACh could activate nAChRs. Because the result was depression 
of synaptic transmission (including mPSCs), it seemed feasible that background 
activation of nAChRs, at network and presynaptic levels, facilitated glutamatergic 
currents perhaps by a dual phenomenon, namely membrane depolarization and 
increase in their quantal size. Postsynaptic nAChRs were unavailable to ambient ACh 
because the antagonists did not change the baseline current of HMs. The reason why 
despite histological evidence for cholinergic synapses on HMs (Gilmor et al., 1996; 
Arvidsson et al., 1997; Schäfer et al., 1998; Ferreira et al., 2001), I failed to detect their 
electrophysiological activity remains a matter of conjecture. It is possible that due to the 
postnatal age of the animals the majority of such synapses was still immature. 
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The global contribution by nAChRs to the efficiency of network glutamatergic 
transmission might be inferred from the data with a large, receptor saturating 
concentration of DHβE: the facilitation of glutamatergic transmission amounted to 
about 25 %. From immunohistochemical results and electrophysiological data 
concerning nicotine response block, it is apparent that nAChRs were predominantly 
localized on HMs, a fact that may explain the relatively limited contribution by nAChRs 
to glutamatergic transmission. Analogous inference could not be obtained simply on 
the basis of the experiments with edrophonium, because this AChE inhibitor exerted 
complex effects including boosting ACh actions on muscarinic receptors, the action of 
which could not be prevented by atropine that also blocks a wide variety of nAChRs 
(Zwart and Vijverberg, 1997). When nicotine was applied, a much wider population of 
nAChRs within the slice could be activated. Thus, recruitment of network receptors 
probably depolarized glutamatergic neurons and increased their frequency of release. 
This was manifested via transient facilitation of spontaneous events, which were then 
depressed presumably because of widespread desensitization of nAChRs. Non-linear 
summation of direct and indirect effects subsequent to nAChR activity over a large 
neuronal network could perhaps have cancelled out any changes in event amplitude, 
otherwise observed when nicotinic antagonists were applied.  Synaptic currents evoked 
by focal electrical pulses applied to the reticular formation region were probably 
monosynaptic (see Essin et al., 2002; Sharifullina et al., 2004), thus requiring activation of 
a much smaller circuit that the one responsible for spontaneous activity. In this case, the 
action of nicotine was first facilitatory and then depressant when 0.5 M was applied, 
or outright inhibitory when 0.1 M was used. Because the latter dose is below threshold 
for activating α4β2 or α7 receptors (Chavez-Noriega et al., 1997), it is suggested that 
depression was due to high affinity desensitization proceeding from bound-closed 
receptors (Giniatullin et al., 2005). 
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FIG. 26. Schematic diagram to account for the action of nAChRs on glutamatergic 
transmission in the nucleus hypoglossus. Glutamatergic premotoneurons (grey) impinging 
upon a HM (orange, under patch clamp condition) release glutamate (red dots) from 
endogenous pools following either electrical stimulation (see electrode) or spontaneously via 
local circuits. Glutamate receptors are indicated as grey ellipsoids. Because of the sparse 
cholinergic afferents (black) presumed to have been largely severed during slicing, cholinergic 
synaptic events are not detectable on HM. However, background release of ACh (open 
triangles) takes place and facilitates glutamatergic transmission mainly by acting on presynaptic 
terminals. HM is endowed with extrasynaptic nAChRs (of at least two subtypes) which are 
readily activated and then desensitized by nicotine (green diamonds). nAChRs are also 
expressed by glutamatergic premotoneurons at axonal or somatic level. Such network receptors, 
normally not accessible to endogenous ACh, unless AChE is inhibited, are activated and 
desensitized by nicotine with dual facilitation/depression of excitatory synaptic transmission. 
Note that very small concentrations of nicotine are likely to evoke nAChR desensitization 
without prior application (Paradiso and Steinbach, 2003).  
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6. FUNCTIONAL IMPLICATIONS 
The observation of strong responses mediated by nAChRs on HMs together with 
immunohistochemical demonstration of such receptors concur to suggest that the 
excitability of HMs can be powerfully upregulated by cholinergic agonists, including 
nicotine. Although nicotine is known to stimulate respiration via an action on 
respiratory brainstem neurons (Shao and Feldman, 2001, 2002), the present data show 
that direct stimulation by nicotine of nAChRs on HMs, which are phasically activated 
during inspiration, could contribute to changes in the respiratory network output. This 
phenomenon would be particularly important when considering the effects of tobacco 
smoke because even small doses of nicotine evoked clear alterations in excitatory 
synaptic transmission. In such a case nicotine would generate a more widespread action 
involving brainstem circuits and modulating their efficiency. These effects may have 
dramatic consequences during a crucial period such as development, resulting in 
impaired network connections and altered HMs responsiveness. 
Finally, the on-going contribution by nAChRs to glutamatergic transmission reveals an 
additional mechanism for interaction between distinct transmitters at similar synaptic 
sites. In fact, rather than co-release of diverse transmitters like in the case of glycine and 
GABA (Jonas et al., 1998), the release of the excitatory transmitter glutamate would be 
subjected to finely tuned, continuous control by ACh, making this process amenable to 
gain-setting via selective modulation of cholinergic receptors. In this context it is 
interesting that, in the hippocampus, activation of nAChRs by nicotine can up or down-
regulate, in a persistent fashion, the activity of glutamatergic synapses with presumably 
functional consequences for memory storage at molecular level (Ge and Dani, 2005).   
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